Skip to main content
. 2023 May 30;14:1197195. doi: 10.3389/fimmu.2023.1197195

Table 4.

Clinical trial designs that may address challenges and opportunities of enrolling participants with comorbidities.

Challenges Opportunities Designs
Safety concerns
Compliance
Heterogeneity of biology and treatment effects
Improve generalizability of trial results

Personalized decision making

Understand how effects differ due to the presence of a comorbidity or due to age

Utilization of real-world evidence
Adaptive enrichment strategy design

Group sequential design with interim analyses to evaluate excluding specific comorbid conditions based on safety.

Phase IV studies
Designing studies to evaluate safety or efficacy in individuals with comorbidity

Pragmatic trials

Expanding eligibility criteria

Generalizable setting

Master protocols to assess optimal treatment selection

Registry-based randomized clinical trials

Post-approval safety studies